Related Experiment Video

Updated: May 13, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Notch inhibitors for cancer treatment

Ingrid Espinoza1, Lucio Miele

  • 1University of Mississippi, Cancer Institute, Jackson, MS, United States.

Pharmacology & Therapeutics
|March 6, 2013
PubMed

Insights

Notch signaling regulates cell fate and is implicated in cancer. This review explores Notch inhibitors as potential cancer therapeutics, detailing their development and clinical progress.

Area of Science:

  • Cellular biology
  • Developmental biology
  • Oncology

Background:

  • Notch signaling is a conserved pathway crucial for cell fate determination, stem cell renewal, and differentiation.
  • Aberrant Notch signaling is linked to carcinogenesis, cancer stem cell biology, and tumor angiogenesis, positioning it as a therapeutic target.
  • The molecular architecture of Notch receptors, ligands, and activators has guided the development of targeted inhibitors.

Purpose of the Study:

  • To review the fundamental principles of Notch signaling.
  • To elucidate the role of Notch in normal and cancer stem cells.
  • To summarize the development and clinical status of Notch pathway inhibitors for cancer treatment.

Main Methods:

  • Literature review of Notch signaling pathways.
  • Analysis of Notch's role in stem cell biology and cancer.
  • Compilation of data on Notch inhibitor development and clinical trials.

Main Results:

  • Notch pathway inhibitors have demonstrated anti-tumor effects in preclinical cancer models.
  • Combinatorial strategies involving Notch inhibitors and conventional chemotherapy are under active clinical investigation.
  • The review provides an overview of the current progress in developing Notch inhibitors for cancer therapy.

Conclusions:

  • Notch signaling is a critical regulator of cell fate with significant implications in cancer.
  • Notch inhibitors represent a promising therapeutic avenue for oncology.
  • Ongoing clinical trials are evaluating the efficacy and safety of Notch inhibitors in cancer patients.

More Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...